Ryboquin Growth Score CB Rank Heat Score
19
136893
39
Commercial
Health Care
Medical
Pharmaceutical
Announced Date | Transaction Name | Number of Investors | Money Raised | Lead Investors | Funding Type |
|---|---|---|---|---|---|
obfuscated obfuscation | ![]() Series A - Ryboquin | obfuscated obfuscation | |||
obfuscated obfuscation | ![]() Series A - Ryboquin | obfuscated obfuscation | |||
obfuscated obfuscation | ![]() Series A - Ryboquin | obfuscated obfuscation | |||
obfuscated obfuscation | ![]() Series A - Ryboquin | obfuscated obfuscation | |||
obfuscated obfuscation | ![]() Series A - Ryboquin | obfuscated obfuscation |
Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
Brian Souter | ![]() Venture Round - Ryboquin | ||
Brian Souter | ![]() Venture Round - Ryboquin | ||
Brian Souter | ![]() Venture Round - Ryboquin | ||
Brian Souter | ![]() Venture Round - Ryboquin | ||
Brian Souter | ![]() Venture Round - Ryboquin |
Acquiree Name | Announced Date | Price | Transaction Name |
|---|---|---|---|
Nanogenic Solutions | obfuscated obfuscation | obfuscated obfuscation | Nanogenic Solutions acquired by Ryboquin |